|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
|
gptkbp:applicationNumber
|
10/2003,123,456
|
|
gptkbp:applicationType
|
utility
|
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20 claims
|
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
|
gptkbp:contains
|
active pharmaceutical ingredient
|
|
gptkbp:description
|
method of administering a drug
|
|
gptkbp:examiner
|
Jane_Smith
|
|
gptkbp:expirationDate
|
March 15, 2022
|
|
gptkbp:fieldOfInvention
|
pharmaceutical compositions
|
|
gptkbp:fieldOfUse
|
oncology
|
|
gptkbp:filingDate
|
March 15, 2002
|
|
gptkbp:hasAbstract
|
treatment of leukemia
|
|
gptkbp:hasAffiliation
|
high efficacy in clinical trials
|
|
gptkbp:hasAwards
|
cancer cells
|
|
gptkbp:hasCitations
|
gptkb:US_6,123,456_A1
|
|
gptkbp:hasCollaboratedWith
|
ABC_Research_Group
|
|
gptkbp:hasCollaborationsWith
|
collaboration_with_XYZ_University
|
|
gptkbp:hasCompetitors
|
competing products in market
|
|
gptkbp:hasContent
|
3 presentations at oncology conferences
|
|
gptkbp:hasContribution
|
$100 million in sales
|
|
gptkbp:hasFigures
|
patent_image.jpg
|
|
gptkbp:hasFilm
|
nausea
|
|
gptkbp:hasFunding
|
funded_by_NIH
|
|
gptkbp:hasGoals
|
available in multiple countries
|
|
gptkbp:hasLegalEvent
|
maintenance fee paid
|
|
gptkbp:hasLocalCuisine
|
NCT01234567
|
|
gptkbp:hasMerchandise
|
inhibits cell division
|
|
gptkbp:hasOccupation
|
approved_by_EMA
|
|
gptkbp:hasPartnershipsWith
|
gptkb:XYZ_Pharmaceuticals
|
|
gptkbp:hasPerformedAt
|
oral
|
|
gptkbp:hasPersonnel
|
exclusive license
|
|
gptkbp:hasPrograms
|
acceptable safety profile
|
|
gptkbp:hasPublications
|
5 related publications
|
|
gptkbp:hasSpecialty
|
patent portfolio
|
|
gptkbp:hasTechnology
|
technology transferred to partner company
|
|
gptkbp:hasTheme
|
20 years
|
|
gptkbp:hasTransportation
|
tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,071 C61
|
|
gptkbp:internationalClassification
|
A61K 31/00
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issuedBy
|
gptkb:Bristol-Myers_Squibb_Company
|
|
gptkbp:issuedOn
|
September 7, 2004
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:market
|
January 1, 2005
FDA_approved
|
|
gptkbp:patentFamily
|
US_6,789,071_C61_family
|
|
gptkbp:patentNumber
|
6,789,071
|
|
gptkbp:patentType
|
granted patent
|
|
gptkbp:priorityDate
|
March 15, 2001
|
|
gptkbp:relatedPatent
|
gptkb:US_6,789,072_C62
|
|
gptkbp:relatedTo
|
cancer treatment
|
|
gptkbp:researchField
|
cancer research
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Methods for treating cancer
|